ConductScience.org, home

Paper22706173

Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review.

Ishiyama H and 7 others. Am J Clin Oncol, 2014. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review. Papers, record 22706173. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22706173

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review.
PubMed
Journal
Am J Clin Oncol
PubMed
Year
2014
PubMed
Publication types
Journal Article, Systematic Review
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
1.99
iCite
Revised in PubMed
2025-07-28
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ishiyama HHiromichi
2Hirayama TTakahiro
3Jhaveri PPavan
4Satoh TTakefumi
5Paulino ACArnold C
6Xu BBo
7Butler EBEdward Brian
8Teh BSBin S

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
Radiation InjuriesMajor topic
Radiotherapy, AdjuvantMajor topic
Transurethral Resection of ProstateMajor topic
UrethraMajor topic
Urination DisordersMajor topic
Brachytherapy
Constriction, Pathologic
Humans
Laser Therapy
Male
Prostatic Hyperplasia
Risk Factors
Severity of Illness Index
Time Factors
Urogenital System

Source PubMed

Download CSV of topics

Cited by30

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
42814133Determinants of late genitourinary toxicity after definitive radiotherapy with or without intraprostatic simultaneous integrated boost in patients with prior transurethral resection of the prostate.Strahlenther Onkol2026https://conductscience.org/library/papers/42814133PubMed
42203958
Comparative analysis of genitourinary toxicity following bladder outlet obstruction procedures in patients before versus after radiotherapy for localized prostate cancer: a retrospective cohort study using the TriNetX database.
Prostate Cancer Prostatic Dis2026https://conductscience.org/library/papers/42203958PubMed
42093677External beam focal boost radiotherapy to intraprostatic lesions in prostate cancer: a scoping review.Phys Imaging Radiat Oncol2026https://conductscience.org/library/papers/42093677PubMed
41831200Late urinary toxicity after prostate intensity-modulated radiation therapy for patients with history of invasive interventions for prostate or bladder.Jpn J Radiol2026https://conductscience.org/library/papers/41831200PubMed
41531161Genitourinary Toxicity, Function, and Quality of Life in Patients Undergoing Prostate Radiation Therapy-A Scoping Review.Low Urin Tract Symptoms2026https://conductscience.org/library/papers/41531161PubMed
41230159Management of prostatic necrosis and the devastated bladder outlet-a narrative review.Transl Androl Urol2025https://conductscience.org/library/papers/41230159PubMed
41186693Does transurethral resection of prostate increase toxicity risk after simultaneous integrated boost radiotherapy? A matched cohort study with long-term follow-up.Strahlenther Onkol2026https://conductscience.org/library/papers/41186693PubMed
40697722Orchiepididymitis as a rare complication of TURP performed four weeks after high-dose-rate brachytherapy for prostate cancer.J Contemp Brachytherapy2025https://conductscience.org/library/papers/40697722PubMed
39851963Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity.Curr Oncol2025https://conductscience.org/library/papers/39851963PubMed
39410023
Effect of Prior Transurethral Prostate Resection (TURP) or Laser Enucleation (ThuLEP) on Radiotherapy-Induced Toxicity and Quality of Life in Prostate Cancer Patients Undergoing Definitive Radiotherapy.
Cancers (Basel)2024https://conductscience.org/library/papers/39410023PubMed
39230728Functional outcomes following external beam radiation therapy for patients with prior holmium laser enucleation of the prostate.World J Urol2024https://conductscience.org/library/papers/39230728PubMed
39200769Results of Adjustable Trans-Obturator Male System for Stress Urinary Incontinence after Transurethral Resection or Holmium Laser Enucleation of the Prostate: International Multicenter Study.J Clin Med2024https://conductscience.org/library/papers/39200769PubMed
38750347Management of the Devastated Bladder Outlet after Prostate CANCER Treatment.Curr Urol Rep2024https://conductscience.org/library/papers/38750347PubMed
38681137Extreme hypofractionated stereotactic radiotherapy for localized prostate Cancer: Efficacy and late urinary toxicity according to transurethral resection of the prostate history.Clin Transl Radiat Oncol2024https://conductscience.org/library/papers/38681137PubMed
38179576Stereotactic body radiation therapy for prostate cancer after surgical treatment of prostatic obstruction: Impact on urinary morbidity and mitigation strategies.Clin Transl Radiat Oncol2024https://conductscience.org/library/papers/38179576PubMed
35116437Urological complications after radiation therapy-nothing ventured, nothing gained: a Narrative Review.Transl Cancer Res2021https://conductscience.org/library/papers/35116437PubMed
35024634Primary Tumor Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy.Eur Urol Open Sci2022https://conductscience.org/library/papers/35024634PubMed
34774676SABR for High-Risk Prostate Cancer: A Prospective Multilevel MRI-Based Dose Escalation Trial.Int J Radiat Oncol Biol Phys2022https://conductscience.org/library/papers/34774676PubMed
34768438Devastated Bladder Outlet in Pelvic Cancer Survivors: Issues on Surgical Reconstruction and Quality of Life.J Clin Med2021https://conductscience.org/library/papers/34768438PubMed
34164950High-dose-rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome.Cancer Rep (Hoboken)2022https://conductscience.org/library/papers/34164950PubMed

See all 30 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22706173

GET https://conductscience.org/api/papers/v1/22706173/cited_by?page=2